PALO
ALTO, Calif., May 27, 2022
Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company
committed to researching, developing and commercializing
transformative therapeutics to treat high prevalence retinal
diseases, announced today that management will present at the
Jefferies Global Healthcare Conference in New York, NY on Thursday, June 9, 2022, at 11:30 a.m. Pacific Time (2:30 p.m. Eastern Time).
A live webcast of the presentation will be available on the
"Events and Presentations" section of Kodiak's website at
http://ir.kodiak.com/ and will remain available for replay for
a limited time following the event.
About Kodiak Sciences
Inc.
Kodiak (Nasdaq: KOD) is a biopharmaceutical company committed to
researching, developing and commercializing transformative
therapeutics to treat high prevalence retinal diseases. Founded in
2009, we are focused on bringing new science to the design and
manufacture of next generation retinal medicines to prevent and
treat the leading causes of blindness globally. Our ABC Platform™
uses molecular engineering to merge the fields of antibody-based
and chemistry-based therapies and is at the core of Kodiak's
discovery engine. Kodiak's lead product candidate, KSI-301, is a
novel anti-VEGF antibody biopolymer conjugate being developed for
the treatment of retinal vascular diseases including wet
age-related macular degeneration, the leading cause of blindness in
elderly patients in the developed world, and diabetic eye diseases,
the leading cause of blindness in working-age patients in the
developed world. Kodiak has leveraged its ABC Platform to build a
pipeline of product candidates in various stages of development.
KSI-501 is our dual inhibitor antibody biopolymer conjugate
targeting both VEGF (VEGF-trap) and IL-6 (anti-IL-6 antibody) for
the treatment of retinal diseases. We are expanding our early
research pipeline to include ABC Platform based triplet inhibitors
for multifactorial retinal diseases such as dry AMD and glaucoma.
Kodiak is based in Palo Alto, CA.
For more information, please visit www.kodiak.com.
View original
content:https://www.prnewswire.com/news-releases/kodiak-sciences-to-present-at-the-jefferies-global-healthcare-conference-301556406.html
SOURCE Kodiak Sciences Inc.